Seres Therapeutics Inc (NASDAQ:MCRB)

7.52
Delayed Data
As of Jan 21
 -0.10 / -1.31%
Today’s Change
5.41
Today|||52-Week Range
29.90
-9.72%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Seres Therapeutics Inc have a median target of 17.50, with a high estimate of 32.00 and a low estimate of 7.00. The median estimate represents a +132.71% increase from the last price of 7.52.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Seres Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.44
Sales
$12.3M
Reporting Date
Mar 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -160.65%
 
 
 
 
 
 
Growthannually 45.04%
 
 
 
 
 
 

Sales

Growthquarterly -90.33%
 
 
 
 
 
 
Growthannually 350.67%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.